Anacor Scores $100M In Valeant Fungus Drug Feud

Valeant Pharmaceuticals International Inc. has been ordered to cough up $100 million to Anacor Pharmaceuticals Inc. in arbitration over a contract dispute concerning Valeant's developmental nail fungus treatment, the companies said Friday. ...read more

  • Tags: